MedTrace Logo

Wich is the Best Dressing in Wounds by Primary Surgery of THA and / or TKA?

NCT03190447 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 560

Last updated 2020-03-09

No results posted yet for this study

Summary

Surgical wounds are covered to prevent bleeding, absorb the exudates and provide a barrier against external contamination. Currently, in Corporació PT after orthopedic surgery, traditional occlusive dressing of sterile gauze and non-woven hypoallergenic adhesive tape is placed. In many cases the appearance of blistering caused by the use of these conventional dressings is observed, which increases the risk of infection, pain and the final cost of the procedure. There are other types of dressings that could improve these aspects but comparative data are not currently available. Main objective: to identify the dressing that better preserves the integrity of the skin.

Design: Prospective randomized comparative study of 5 types of dressings used in total knee and hip arthroplasty surgical wounds (TKA and THA).

Secondary Objectives: To identify the dressing that provides greater advantages and minor inconveniences in TKA and THA surgery.

Study population: Patients older than 18 years undergoing fast track primary TKA or THA. 110 patients

Conditions

  • Occlusive Dressings
  • Nursing
  • Knee Surgery
  • Hip Surgery

Interventions

DEVICE

Aquacel Surgical®

Measuring the skin integrity with each dressing and the patient satisfaction

DEVICE

Mepilex Border post-op®

Measuring the skin integrity with each dressing and the patient satisfaction

DEVICE

Opsite post-op visible®

Measuring the skin integrity with each dressing and the patient satisfaction

DEVICE

Urgotul ABSORB border silicona®

Measuring the skin integrity with each dressing and the patient satisfaction

DEVICE

Conventional dressing

Measuring the skin integrity with each dressing and the patient satisfaction

Sponsors & Collaborators

  • Fundació Parc Taulí

    collaborator UNKNOWN

  • Department of Health, Generalitat de Catalunya

    collaborator OTHER_GOV

  • Corporacion Parc Tauli

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-20
Primary Completion
2019-12-30
Completion
2019-12-31

Countries

  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03190447 on ClinicalTrials.gov